This is the authors' abstract. We don't add key points for this paper.
Over the past few years, considerable attention has focused on cannabidiol (CBD), a major nonpsychotropic constituent of cannabis. The authors present a review on the chemistry of CBD and discuss the anticonvulsive, antianxiety, antipsychotic, antinausea, and antirheumatoid arthritic properties of CBD. CBD does not bind to the known cannabinoid receptors, and its mechanism of action is yet unknown. It is possible that, in part at least, its effects are due to its recently discovered inhibition of anandamide uptake and hydrolysis and to its antioxidative effect.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mechoulam et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: